These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8466217

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impaired antigen presentation in toxic epidermal necrolysis.
    Bagot M, Charue D, Heslan M, Wechsler J, Roujeau JC, Revuz J.
    Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.
    Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC.
    J Allergy Clin Immunol; 2004 Nov; 114(5):1209-15. PubMed ID: 15536433
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.
    Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y.
    Arch Dermatol; 1991 Jun; 127(6):851-5. PubMed ID: 2036032
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin.
    Mayorga C, Torres MJ, Corzo JL, Sanchez-Sabate E, Alvarez J, Vera A, Posadas S, Jurado A, Blanca M.
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):86-91. PubMed ID: 12877456
    [Abstract] [Full Text] [Related]

  • 17. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME.
    Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.